8-K: Research Frontiers Receives Nasdaq Deficiency Notices
Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Research Frontiers Incorporated has been notified by Nasdaq of non-compliance with minimum bid price and market value requirements.
Summary
- Research Frontiers received two deficiency letters from Nasdaq on June 2, 2026.
- The company failed to maintain the $1.00 minimum bid price requirement for 30 consecutive business days.
- The company failed to maintain the $35 million minimum Market Value of Listed Securities (MVLS) requirement for 30 consecutive business days.
- The company does not currently meet alternative listing standards for stockholders' equity or net income.
- The company has until November 30, 2026, to regain compliance with both requirements.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a significant negative development, as the company is now under the threat of delisting and lacks the financial metrics to qualify for alternative listing standards.
Positives
- The company has a 180-day grace period to regain compliance, allowing time for market recovery.
- Trading of common stock under the symbol REFR remains unaffected at this time.
Negatives
- Failure to meet Nasdaq's minimum bid price requirement.
- Failure to meet Nasdaq's minimum Market Value of Listed Securities (MVLS) requirement.
- Inability to meet alternative listing standards regarding stockholders' equity and net income.
Risks
- Potential delisting from The Nasdaq Capital Market if compliance is not regained by November 30, 2026.
- Uncertainty regarding the company's ability to improve market valuation or bid price within the allotted timeframe.
- Risk of future delisting if other continued listing standards are not maintained.
Future Outlook
The company intends to monitor its stock price and market value to regain compliance, explicitly stating it does not currently intend to perform a reverse stock split.
Management Comments
- The company's objective is to regain compliance through improved market valuation and bid-price performance.
- There can be no assurance that the company will regain compliance within the applicable compliance period.
Industry Context
StockSavvy.ai notes that small-cap technology firms often face heightened scrutiny during periods of market volatility, and receiving deficiency notices is a common, albeit serious, hurdle for companies struggling with liquidity and valuation in the current economic climate.
Comparison to Industry Standards
- The company's inability to meet alternative standards (equity/net income) places it in a weaker position compared to peers that maintain profitability or sufficient capital buffers.
- The reliance on organic market improvement rather than corporate action (like a reverse split) is a conservative approach compared to industry peers who often use splits to force compliance.
Stakeholder Impact
- Shareholders face increased volatility and potential liquidity risks associated with delisting threats.
- Creditors may reassess the company's creditworthiness given the failure to meet listing standards.
Next Steps
- Monitor closing bid price and MVLS.
- Attempt to regain compliance by November 30, 2026.
- Evaluate options to improve market valuation.
Key Dates
| Date | Description |
|---|---|
| 2026-04-15 | Start of the 30-day period for bid price deficiency measurement. |
| 2026-04-20 | Start of the 30-day period for MVLS deficiency measurement. |
| 2026-06-01 | End of the 30-day measurement period for both deficiencies. |
| 2026-06-02 | Date of receipt of Nasdaq deficiency notification letters. |
| 2026-11-30 | Deadline to regain compliance with Nasdaq listing requirements. |
Recommendation
sellThe combination of failing two listing requirements and not meeting alternative financial standards suggests fundamental weakness, making the stock a high-risk hold or sell until a clear path to compliance or profitability is established.
Keywords
Nasdaq, delisting, REFR, compliance, market value, bid price
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.